Merozoite surface protein 1 of Plasmodium vivax induces a protective response against Plasmodium cynomolgi challenge in rhesus monkeys

Infection and Immunity

Volumn 73, Issue 9, 2005, Pages 5936-5944

  Dutta, Sheetij ^a   Kaushal, Deep C ^b   Ware, Lisa A ^a   Puri, Sunil K ^b   Kaushal, Nuzhat A ^b   Narula, Atul ^b   Upadhyaya, D S ^b   Lanar, David E ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; IMMUNOGENICITY; MALARIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITEMIA; PLASMODIUM CYNOMOLGI; PLASMODIUM VIVAX; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN SYNTHESIS; RHESUS MONKEY; SEQUENCE ANALYSIS;

ANIMALS; MACACA MULATTA; MALARIA; MALARIA VACCINES; MEROZOITE SURFACE PROTEIN 1; MOLECULAR SEQUENCE DATA; PLASMODIUM CYNOMOLGI; PLASMODIUM VIVAX; RECOMBINANT PROTEINS; SEQUENCE ANALYSIS, DNA;

EID: 23944502355     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.9.5936-5944.2005     Document Type: Article

References (46)

1. Ahlborg, N., I. T. Ling, W. Howard, A. A. Holder, and E. M. Riley. 2002. Protective immune responses to the 42-kilodalton (kDa) region of Plasmodium yoelii merozoite surface protein 1 are induced by the C-terminal 19-kDa region but not by the adjacent 33-kDa region. Infect. Immun. 70:820-825.
2. Aikawa, M., L. H. Miller, and J. Rabbege. 1975. Caveola-vesicle complexes in the plasmalemma of erythrocytes infected by Plasmodium vivax and P. cynomolgi. Unique structures related to Schuffner's dots. Am. J. Pathol. 79:285-300.
3. Angov, E., B. M. Aufiero, A. M. Turgeon, M. Van Handenhove, C. F. Ockenhouse, K. E. Kester, D. S. Walsh, J. S. McBride, M. C. Dubois, J. Cohen, J. D. Haynes, K. H. Eckels, D. G. Heppner, W. R. Ballou, C. L. Diggs, and J. A. Lyon. 2003. Development and pre-clinical analysis of a Plasmodium falciparum merozoite surface protein-1(42) malaria vaccine. Mol. Biochem. Parasitol. 128:195-204.
4. Ballou, W. R., M. Arevalo-Herrera, D. Carucci, T. L. Richie, G. Corradin, C. L. Diggs, P. Druilhe, B. K. Giersing, A. Saul, D. G. Heppner, K. E. Kester, D. E. Lanar, J. Lyon, A. V. Hill, W. Pan, and J. D. Cohen. 2004. Update on the clinical development of candidate malaria vaccines. Am. J. Trop. Med. Hyg. 71(Suppl. 2):239-247.
5. Benjamin, P. A., I. T. Ling, G. Clottey, L. M. Valero, S. A. Ogun, S. L. Fleck, D. Walliker, W. D. Morgan, B. Birdsall, J. Feeney, and A. A. Holder. 1999. Antigenic and sequence diversity at the C-terminus of the merozoite surface protein-1 from rodent malaria isolates, and the binding of protective monoclonal antibodies. Mol. Biochem. Parasitol. 104:147-156.
6. Bessette, P. H., F. Aslund, J. Beckwith, and G. Georgiou. 1999. Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm. Proc. Natl. Acad. Sci. USA 96:13703-13708.
7. Blackman, M. J., I. T. Ling, S. C. Nicholls, and A. A. Holder. 1991. Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Mol. Biochem. Parasitol. 49:29-33.
8. Chitarra, V., I. Holm, G. A. Bentley, S. Petres, and S. Longacre. 1999. The crystal structure of C-terminal merozoite surface protein 1 at 1.8 A resolution, a highly protective malaria vaccine candidate. Mol. Cell 3:457-464.
9. Chang, S. P., S. E. Case, W. L. Gosnell, A. Hashimoto, K. J. Kramer, L. Q. Tarn, C. Q. Hashiro, C. M. Nikaido, H. L. Gibson, C. T. Lee-Ng, P. J. Barr, B. T. Yokota, and G. S. Hut. 1996. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria. Infect. Immun. 64:253-261.
10. Chitnis, C. E., and M. J. Blackman. 2000. Host cell invasion by malaria parasites. Parasitol. Today 16:411-415.
11. Collins, W. E., D. C. Kaslow, J. S. Sullivan, C. L. Morris, G. G. Galland, C. Yang, A. M. Saekhou, L. Xiao, and A. A. Lal. 1999. Testing the efficacy of a recombinant merozoite surface protein MSP-1(19) of Plasmodium vivax in Saimiri boliviensis monkeys. Am. J. Trop. Med. Hyg. 60:350-356.
12. Darko, C. A., E. Angov, W. E. Collins, E. S. Bergmann-Leitner, A. S. Girouard, S. L. Hitt, J. S. McBride, C. L. Diggs, A. A. Holder, C. A. Long, J. W. Barnwell, and J. A. Lyon. 2005. The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites. Infect. Immun. 73:287-297.
13. Dutta, S., P. Malhotra, and V. S. Chauhan. 1995. Sequence analysis of apical membrane antigen 1 (AMA-1) of Plasmodium cynomolgi bastianelli. Mol. Biochem. Parasitol. 73:267-270.
14. Dutta, S., L. W. Ware, A. Barbosa, C. F. Ockenhouse, and D. E. Lanar. 2001. Purification, characterization, and immunogenicity of a disulfide cross-linked Plasmodium vivax vaccine candidate antigen, merozoite surface protein 1, expressed in Escherichia coli. Infect. Immun. 69:5464-5470.
15. Dutta, S., P. V. Lalitha, L. A. Ware, A. Barbosa, J. K. Moch, M. A. Vassell, B. B. Fileta, S. Kitov, N. Kolodny, D. G. Heppner, J. D. Haynes, and D. E. Lanar. 2002. Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli. Infect. Immun. 70:3101-3110.
16. Galinski, M. R., D. E. Arnot, A. H. Cochrane, J. W. Barnwell, R. S. Nussenzweig, and V. Enea. 1987. The circumsporozoite gene of the Plasmodium cynomolgi complex. Cell 48:311-319.
17. Galinski, M. R., C. C. Medina, P. Ingravallo, and J. W. Barnwell. 1992. A reticulocyte-binding protein complex of Plasmodium vivax merozoites. Cell 69:1213-1226.
18. Gibson, H. L., J. E. Tucker, D. C. Kaslow, A. U. Krettli, W. E. Collins, M. C. Kiefer, I. C. Bathurst, and P. J. Barr. 1992. Structure and expression of the gene for Pv200, a major blood-stage surface antigen of Plasmodium vivax. Mol. Biochem. Parasitol. 50:325-333.
19. Holm, I., F. Nato, K. N. Mendis, S. Longacre. 1997. Characterization of C-terminal merozoite surface protein-1 baculovirus recombinant proteins from Plasmodium vivax and Plasmodium cynomolgi as recognized by the natural anti-parasite immune response. Mol. Biochem. Parasitol. 89:313-319.
20. Kamboj, K. K., J. W. Barnwell, R. S. Nussenzweig, and A. H. Cochrane. 1988. Characterization of cross-reactive blood-stage antigens of the Plasmodium cynomolgi complex using anti-Plasmodium vivax monoclonal antibodies. J. Parasitol. 74:403-408.
21. Kaushal, D. C., and N. A. Kaushal. 2002. Diagnosis of malaria by detection of plasmodial lactate dehydrogenase with an immunodot enzyme assay. Immunol. Investig. 31:93-106.
22. Kocken, C. H., M. A. Dubbeld, A. Van Der Wel, J. T. Pronk, A. P. Waters, J. A. Langermans, and A. W. Thomas. 1999. High-level expression of Plasmodium vivax apical membrane antigen 1 (AMA-1) in Pichia pastoris: strong immunogenicity in Macaca mulatta immunized with P. vivax AMA-1 and adjuvant SBAS2. Infect. Immun. 67:43-49.
23. Krotoski, W. A., W. E. Collins, R. S. Bray, P. C. Garnham, F. B. Cogswell, R. W. Gwadz, R. Killick-Kendrick, R. Wolf, R. Sinden, L. C. Koontz, and P. S. Stanfill. 1982. Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection. Am. J. Trop. Med. Hyg. 31:1291-1293.
24. Kumar, S., W. Collins, A. Egan, A. Yadava, O. Garraud, M. J. Blackman, J. A. Guevara Patino, C. Diggs, and D. C. Kaslow. 2000. Immunogenicity and efficacy in Aotus monkeys of four recombinant Plasmodium falciparum vaccines in multiple adjuvant formulations based on the 19-kilodalton C terminus of merozoite surface protein 1. Infect. Immun. 68:2215-2223.
25. Kuvin, S. F., H. K. Beye, F. Stohlman, Jr., P. G. Contacos, and G. R. Coatney. 1963. Malaria in man. Infection by Plasmodium vivax and the B strain of Plasmodium cynomolgi. JAMA 184:1018-1020.
26. Kuvin, S. F., H. K. Beye, F. Stohlman Jr., P. G. Contacos, and G. R. Coatney. 1962. Clinical and physiological responses in sporozoite-induced B strain Plasmodium cynomolgi and Plasmodium vivax infections in normal volunteers. Trans. R Soc. Trop. Med. Hyg. 56:371-378.
27. Lawrence, G., Q. Q. Cheng, C. Reed, D. Taylor, A. Stowers, N. Cloonan, C. Rzepczyk, A. Smillie, K. Anderson, D. Pombo, A. Allworth, D. Eisen, R. Anders, and A. Saul. 2000. Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers. Vaccine 18:1925-1931.
28. Ling, I. T., S. A. Ogun, P. Momin, R. L. Richards, N. Garcon, J. Cohen, W. R. Ballou, and A. A. Holder. 1997. Immunization against the murine malaria parasite Plasmodium yoelii using a recombinant protein with adjuvants developed for clinical use. Vaccine 15:1562-1567.
29. Ling, I. T., S. A. Ogun, and A. A. Holder. 1994. Immunization against malaria with a recombinant protein. Parasite Immunol 16:63-67.
30. Longacre, S., K. N. Mendis, and P. H. David. 1994. Plasmodium vivax merozoite surface protein 1 C-terminal recombinant proteins in baculovirus. Mol. Biochem. Parasitol. 64:191-205.
31. Longacre, S. 1995. The Plasmodium cynomolgi merozoite surface protein 1 C-terminal sequence and its homologies with other Plasmodium species. Mol. Biochem. Parasitol. 74:105-111.
32. Okenu, D. M., P. Malhotra, P. V. Lalitha, C. E. Chitnis, and V. S. Chauhan. 1997. Cloning and sequence analysis of a gene encoding an erythrocyte binding protein from Plasmodium cynomolgi. Mol. Biochem. Parasitol. 89:301-306.
33. Perera, K. L., S. M. Handunnetti, I. Holm, S. Longacre, and K. Mendis. 1998. Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria. Infect. Immun. 66:1500-1506.
34. Puri, S. K., K. K. Kamboj, and G. P. Dutta. 1989. Infectivity studies on Anopheles stephensi using P. cynomolgi B infection in rhesus monkeys. Trop. Med. Parasitol. 40:409-411.
35. Putaporntip, C., S. Jongwutiwes, N. Sakihama, M. U. Ferreira, W. G. Kho, A. Kaneko, H. Kanbara, T. Hattori, and K. Tanabe. 2002. Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus. Proc. Natl. Acad. Sci. USA 99:16348-16353.
36. Sachdeva, S., G. Ahmad, P. Malhotra, P. Mukherjee, and V. S. Chauhan. 2004. Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kilodalton fragments expressed in Escherichia coli. Infect. Immun. 72:5775-5782.
37. Singh, S., M. C. Kennedy, C. A. Long, A. J. Saul, L. H. Miller, and A. W. Stowers. 2003. Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1. Infect. Immun. 71:6766-6774.
38. Snedecor, G. W., and W. G. Cochran. 1980. Statistical methods, p. 234-245. Iowa State University Press, Ames, Iowa.
39. Tobie, J. E., S. M. Wolff, and G. M. Jeffery. 1966. Immune response of man to inoculation with Plasmodium cynomolgi and challenge with P. vivax. Lancetii:300-302.
40. Uthaipibull, C., B. Auflero, S. E. Syed, B. Hansen, J. A. Guevara Patino, E. Angov, I. T. Ling, K. Fegeding, W. D. Morgan, C. Ockenhouse, B. Birdsall, J. Feeney, J. A. Lyon, and A. A. Holder. 2001. Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum. J. Mol. Biol. 307:1381-1394.
41. Voller, A., D. E. Bidwell, and A. Bartlett. 1976. Enzyme immunoassays in diagnostic medicine. Theory and practice. Bull. W.H.O. 53:55-65.
42. Walther, M., S. Dunachie, S. M. Keating, J. Vuola, T. Berthoud, A. Schmidt, C. Maier, L. F. Andrews, R. Andersen, S. Gilbert, I. Poulton, D. Webster, F. Dubovsky, E. Tierney, P. Sarpotdar, S. Correa, A. Huntcooke, G. Butcher, J. E. Williams, R. B. Sinden, G. Thornton, and A. V. S. Hill. 2005. A. Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720. Vaccine 23:857-864.
43. Waters, A. P., D. G. Higgins, and T. F. McCutchan. 1993. Evolutionary relatedness of some primate models of Plasmodium. Mol. Biol. Evol. 10:914-923.
44. Wipasa, J., H. Xu, M. Makobongo, M. Gatton, A. Stowers, and M. F. Good. 2002. Nature and specificity of the required protective immune response that develops postchallenge in mice vaccinated with the 19-kilodalton fragment of Plasmodium yoelii merozoite surface protein 1. Infect. Immun. 70:6013-6020.
45. Yang, C., W. E. Collins, J. S. Sullivan, D. C. Kaslow, L. Xiao, and A. A. Lal. 1999. Partial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant. Infect. Immun. 67:342-349.
46. Yang, C., W. E. Collins, and P. Millet. 1994. Immunologic characterization of Plasmodium vivax antigens using Plasmodium cynomolgi liver stage-primed immune sera. Am. J. Trop. Med. Hyg. 51:365-371.